Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Orphazyme A/S buy Amped

Orphazyme A/S
Start price
€6.55
21.06.21 / 0%
Target price
-
21.06.22
Performance (%)
-3.82%
End price
€6.30
21.06.21
Summary
This prediction ended on 21.06.21 with a price of €6.30. With a performance of -3.82%, the BUY prediction by Amped finished with a loss. This prediction was marked as speculative and is excluded from Amped's performance statistics.
Performance without dividends (%)
Name 1w 1m 1y 3y
Orphazyme A/S - - - -
iShares Core DAX® 0.795% 1.458% 17.980% 69.888%
iShares Nasdaq 100 -3.088% -0.762% 3.169% 101.814%
iShares Nikkei 225® -0.952% -2.268% 12.208% 45.300%
iShares S&P 500 -1.393% 0.199% 1.698% 63.763%

According to Amped what are the pros and cons of Orphazyme A/S for the foreseeable future?

Pros
EBIT growth >5% per year expected
Capable Management
Known brand
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Fair valuation
Good culture
Sustainability is important
Top 10 in its market
Very Future proof/growth oriented business model
Cons
Few uniques
Dependend from some customers or products
Significant cyclical dependencies

Comments by Amped for this prediction

In the thread Orphazyme A/s diskutieren

Buy Orphazyme A/S

Amped 
0
Report Share
21.06.21 Buy -3.82%
In the thread Trading Orphazyme A/s
Prediction Buy
Perf. (%) -3.82%
Target price
Change
Ends at 21.06.22

Buy beendet

Amped 
0
Report Share
21.06.21

Stopped prediction by Amped for Orphazyme A/S

buy
Orphazyme A/S

Start price
Target price
Perf. (%)
€6.80
25.06.21
-
21.06.22
-88.60%
22.06.22

EBIT growth >5% per year expected
Capable Management
Few uniques
Dependend from some customers or products
Amped 
25.06.21 0%
sell
Orphazyme A/S

Start price
Target price
Perf. (%)
€0.78
25.06.21
-
21.06.22
-
25.06.21

EBIT growth >5% per year expected
Capable Management
Few uniques
Dependend from some customers or products
Amped 
25.06.21 0%
buy
Orphazyme A/S

Start price
Target price
Perf. (%)
€6.90
23.06.21
-
21.06.22
-1.45%
25.06.21

EBIT growth >5% per year expected
Capable Management
Few uniques
Dependend from some customers or products
Amped 
23.06.21 0%
sell
Orphazyme A/S

Start price
Target price
Perf. (%)
€6.30
21.06.21
-
21.06.22
9.52%
23.06.21

EBIT growth >5% per year expected
Capable Management
Few uniques
Dependend from some customers or products
Amped 
21.06.21 0%